XML 116 R90.htm IDEA: XBRL DOCUMENT v3.24.0.1
DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES - Schedule of Effect of Fair Value and Cash Flow Hedge Accounting on the Consolidated Condensed Statements of Operations (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Derivative Instruments, Gain (Loss)      
Cost of sales $ (1,379.8) $ (1,080.4) $ (1,248.9)
Selling, general, and administrative expenses (1,824.6) (1,567.6) (1,493.7)
Other income, net 14.4 2.6 $ 12.7
Foreign currency contracts | Cost of sales      
Gain (loss) on fair value hedging relationships:      
Hedged items 0.0 0.0  
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach 0.0 0.0  
Gain (loss) on cash flow hedging relationships:      
Amount of gain (loss) reclassified from accumulated OCI into income 58.9 88.4  
Foreign currency contracts | Cost of sales | Derivatives designated as hedging instruments      
Gain (loss) on fair value hedging relationships:      
Derivatives designated as hedging instruments 0.0 0.0  
Foreign currency contracts | Other income, net      
Gain (loss) on fair value hedging relationships:      
Hedged items (9.2) 5.5  
Amount excluded from effectiveness testing recognized in earnings based on an amortization approach 4.7 1.6  
Gain (loss) on cash flow hedging relationships:      
Amount of gain (loss) reclassified from accumulated OCI into income 0.0 0.0  
Foreign currency contracts | Other income, net | Derivatives designated as hedging instruments      
Gain (loss) on fair value hedging relationships:      
Derivatives designated as hedging instruments $ 9.2 $ (5.5)